Effect of evening primrose oil (EPO) on Polycystic Ovary Syndrome

Effect of evening primrose oil (EPO) on Biochemical Indices and Ultrasound Data in 18-24 Years Old Girls with Polycystic Ovary Syndrome

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200722048175N1

Enrollment

Registered

2020-09-20

Start date

2020-08-05

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polycystic Ovary Syndrome. Polycystic ovarian syndrome

Interventions

Intervention 1: Intervention group: administration of evening primorse oil for 3 months. Intervention 2: Control group: administration of placebo for 3 months.

Eligibility

Sex/Gender

Female

Age

18 Years to 24 Years

Inclusion criteria

Inclusion criteria: Polycystic Ovary Syndrome

Exclusion criteria

Exclusion criteria: Metabolic diseases

Design outcomes

Primary

Measure	Time frame
Testostrone. Timepoint: Before and after the intervention. Method of measurement: elisa.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasomeh Rezaie

Sanandaj University of Medical Sciences

masume.rezaii1366@gmail.com+98 87 3315 3574

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026